Accelerate Diagnostics completes asset sale and moves toward liquidation plan

Published 18/08/2025, 22:10
Accelerate Diagnostics completes asset sale and moves toward liquidation plan

Accelerate Diagnostics, Inc. (OTC:AXDXQ), which has been struggling with a significant debt burden of $66.58 million and negative EBITDA of -$31.89 million, announced Monday that it has completed the sale of certain assets and liabilities to an affiliate of Indaba Capital Management, L.P., as part of its ongoing Chapter 11 bankruptcy proceedings in the United States Bankruptcy Court for the District of Delaware. InvestingPro data shows the company has been rapidly burning through cash, with negative free cash flow of -$24.7 million.

According to a statement in the company’s SEC filing, the sale was finalized on August 8, following an amended and restated asset purchase agreement entered into the same day. The amended agreement modifies an earlier asset purchase agreement approved by the court on July 14, 2025, and results in the buyer acquiring specific assets and liabilities rather than substantially all of the company’s assets.

On August 13, the bankruptcy court confirmed the Second Amended Combined Disclosure Statement and Chapter 11 Plan of Liquidation for Accelerate Diagnostics and its U.S. subsidiary, Accelerate Diagnostics Texas, LLC. The company expects the plan’s effective date to occur on or about August 18, or as soon as reasonably practicable thereafter.

As of the confirmation order date, Accelerate Diagnostics reported approximately 25,477,516 shares of common stock outstanding. Under the terms of the liquidation plan, all outstanding shares of common stock and warrants will be canceled and discharged, and holders of these equity interests will not receive or retain any property or value.

The company’s common stock, previously suspended from trading on the Nasdaq Capital Market on May 15, 2025, is currently quoted on the OTC Pink marketplace under the symbol AXDXQ.

Accelerate Diagnostics stated in the filing that it is unable to provide pro forma financial information reflecting the sale transaction without unreasonable effort or expense.

This article is based on a press release statement contained in the company’s Form 8-K filed with the Securities and Exchange Commission.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.